PTH:ARCA-PowerShares DWA Healthcare Momentum Portfolio (USD)

ETF | Health | NYSE Arca

Last Closing

USD 43.05

Change

+0.76 (+1.80)%

Market Cap

USD 0.07B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dorsey Wright? Healthcare Technical Leaders Index (the "underlying index"). The fund generally will invest at least 90% of its total assets in common stocks of companies that comprise the underlying index. The underlying index is composed of at least 30 common stocks of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics.

Inception Date: 12/10/2006

Primary Benchmark: Dorsey Wright Hlthcr Tech Ldrs TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.7%

Management Expense Ratio: 0.60 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
IBB iShares Biotechnology ETF 0.47 %

-0.01 (-0.01%)

USD 7.39B
PPH VanEck Pharmaceutical ETF 0.36 %

-0.40 (-0.43%)

USD 0.69B
BBH VanEck Biotech ETF 0.35 %

-0.05 (-0.03%)

USD 0.45B
PSCH Invesco S&P SmallCap Health Ca.. 0.29 %

-0.49 (-1.10%)

USD 0.19B
GNOM Global X Genomics & Biotechnol.. 0.00 %

-0.02 (-0.20%)

USD 0.08B
FTXH First Trust Nasdaq Pharmaceuti.. 0.60 %

+0.17 (+0.61%)

USD 0.02B
CNCR Loncar Cancer Immunotherapy ET.. 0.79 %

-0.13 (-0.86%)

USD 0.01B

ETFs Containing PTH

DWTR 0.00 % 0.15 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.99% 78% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.99% 78% C+ 72% C
Trailing 12 Months  
Capital Gain 7.38% 78% C+ 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.38% 78% C+ 56% F
Trailing 5 Years  
Capital Gain 63.13% 100% F 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 63.13% 89% A- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 12.02% 100% F 71% C-
Dividend Return 12.02% 100% F 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 36.77% 11% F 49% F
Risk Adjusted Return 32.69% 67% D+ 67% D+
Market Capitalization 0.07B 56% F 43% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.